Virological monitoring of hepatitis C treatment in 2009

被引：0
作者：
Cacoub, P. [1 ,2 ]
Halfon, P. [3 ]
机构：
[1] Univ Paris 06, CNRS, UMR 7087, F-75013 Paris 13, France
[2] Hop La Pitie Salpetriere, AP HP, Serv Med Interne, F-75013 Paris, France
[3] Hop Ambroise Pare, Lab Virol Alphabio, Serv Malad Infect, F-13006 Marseille, France
来源：
REVUE DE MEDECINE INTERNE | 2009年 / 30卷 / 10期
关键词：
HCV infection; Hepatitis C; Treatment; ALPHA-2B PLUS RIBAVIRIN; TREATMENT DURATION; PEGINTERFERON ALPHA-2A; VIRUS; GENOTYPE-1; INFECTION; TYPE-1; TRIAL;
D O I：
10.1016/j.revmed.2009.04.005
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：838 / 840
页数：3
相关论文
共 13 条
  • [1] Extended treatment duration for hepatitis C virus type 1: Comparing 48 versus 72 weeks of peginterferon-alfa-2a plus ribavirin
    Berg, T
    von Wagner, M
    Nasser, S
    Sarrazin, C
    Heintges, T
    Gerlach, T
    Buggisch, P
    Goeser, T
    Rasenack, J
    Pape, GR
    Schmidt, WE
    Kallinowski, B
    Klinker, H
    Spengler, U
    Martus, P
    Alshuth, U
    Zeuzem, S
    [J]. GASTROENTEROLOGY, 2006, 130 (04) : 1086 - 1097
  • [2] Peginterferon alfa-2a and ribavirin for 24 weeks in hepatitis C type 1 and 4 patients with rapid virological response
    Ferenci, Peter
    Laferl, Hermann
    Scherzer, Thomas-Matthias
    Gschwantler, Michael
    Maieron, Andreas
    Brunner, Harald
    Stauber, Rudolf
    Bischof, Martin
    Bauer, Bernhard
    Datz, Christian
    Loeschenberger, Karin
    Formann, Elisabeth
    Staufer, Katharina
    Steindl-Munda, Petra
    [J]. GASTROENTEROLOGY, 2008, 135 (02) : 451 - 458
  • [3] Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.
    Fried, MW
    Shiffman, ML
    Reddy, KR
    Smith, C
    Marinos, G
    Goncales, FL
    Haussinger, D
    Diago, M
    Carosi, G
    Dhumeaux, D
    Craxi, A
    Lin, A
    Hoffman, J
    Yu, J
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (13) : 975 - 982
  • [4] Peginterferon-α2a and ribavirin combination therapy in chronic hepatitis C -: A randomized study of treatment duration and ribavirin dose
    Hadziyannis, SJ
    Sette, H
    Morgan, TR
    Balan, V
    Diago, M
    Marcellin, P
    Ramadori, G
    Bodenheimer, H
    Bernstein, D
    Rizzetto, M
    Zeuzem, S
    Pockros, PJ
    Lin, A
    Ackrill, AM
    [J]. ANNALS OF INTERNAL MEDICINE, 2004, 140 (05) : 346 - 355
  • [5] Real-time PCR assays for hepatitis C virus (HCV) RNA quantitation are adequate for clinical management of patients with chronic HCV infection
    Halfon, Philippe
    Bourliere, Marc
    Penaranda, Guillaume
    Khiri, Hacene
    Ouzan, Denis
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2006, 44 (07) : 2507 - 2511
  • [6] Individualized treatment duration for hepatitis C genotype 1 patients: A randomized controlled trial
    Mangia, Alessandra
    Minerva, Nicola
    Bacca, Donato
    Cozzolongo, Raffaele
    Ricci, Giovanni L.
    Carretta, Vito
    Vinelli, Francesco
    Scotto, Gaetano
    Montalto, Giuseppe
    Romano, Mario
    Cristofaro, Giuseppe
    Mottola, Leonardo
    Spirito, Fulvio
    Andriulli, Angelo
    [J]. HEPATOLOGY, 2008, 47 (01) : 43 - 50
  • [7] Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial
    Manns, MP
    McHutchison, JG
    Gordon, SC
    Rustgi, VK
    Shiffman, M
    Reindollar, R
    Goodman, ZD
    Koury, K
    Ling, MH
    Albrecht, JK
    [J]. LANCET, 2001, 358 (9286) : 958 - 965
  • [8] Eradication of hepatitis C virus in patients successfully treated for chronic hepatitis C
    Maylin, Sarah
    Martinot-Peignoux, Michelle
    Moucari, Rami
    Boyer, Nathalie
    Ripault, Marie-Pierre
    Cazals-Hatem, Dominique
    Giuily, Nathalie
    Castelnau, Corinne
    Cardoso, Ana Carolina
    Asselah, Tarik
    Feray, Cyrille
    Nicolas-Chanoine, Marie Helene
    Bedossa, Pierre
    Marcellin, Patrick
    [J]. GASTROENTEROLOGY, 2008, 135 (03) : 821 - 829
  • [9] How to obtain the most effective results when treating chronic hepatitis C virus?
    Ouzan, Denis
    [J]. GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2007, 31 (6-7): : 573 - 577
  • [10] Treatment extension to 72 weeks of peginterferon and ribavirin in hepatitis C genotype 1-infected slow responders
    Pearlman, Brian L.
    Ehleben, Carole
    Saifee, Sophia
    [J]. HEPATOLOGY, 2007, 46 (06) : 1688 - 1694
12